Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYSanofi: CHMP recommends approval of Dupixent® (dupilumab) for asthma indicationPREV STORYAkcea and Ionis Receive Positive EU CHMP Opinion for WAYLIVRATM (volanesorsen)